![Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm](https://preview.redd.it/c7ugbflcndv61.jpg?auto=webp&s=7223cf4e373ba941ebb09e2126f98d23887bb882)
Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm
![Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm](https://preview.redd.it/6e8ei9l7etz61.jpg?auto=webp&s=c273e749c3b370351599d93485ed810b5281e3fc)
Please help, flared up probably due to being allergic to hay/horses which I am working with, I'm currently using Eumovate and cerave which is helping haven't seen a dermatologist yet cause I'm
![Schon im Januar?: Pfizer-Medikament gegen schwere Corona-Verläufe soll bald einsatzbereit sein - Aktie profitiert vorbörslich | Nachricht | finanzen.net Schon im Januar?: Pfizer-Medikament gegen schwere Corona-Verläufe soll bald einsatzbereit sein - Aktie profitiert vorbörslich | Nachricht | finanzen.net](https://images.finanzen.net/mediacenter/Firmen/logos_2011/pfizer-molly-woodward-shutterstock-1960556293-660_w1320.jpg)
Schon im Januar?: Pfizer-Medikament gegen schwere Corona-Verläufe soll bald einsatzbereit sein - Aktie profitiert vorbörslich | Nachricht | finanzen.net
![Bei Dermatitis: Sanofi und Regeneron erzielen Erfolg mit Dupixent bei Kleinkindern | Nachricht | finanzen.net Bei Dermatitis: Sanofi und Regeneron erzielen Erfolg mit Dupixent bei Kleinkindern | Nachricht | finanzen.net](https://images.finanzen.net/mediacenter/unsortiert/sanofi-360b-774_w1320.jpg)
Bei Dermatitis: Sanofi und Regeneron erzielen Erfolg mit Dupixent bei Kleinkindern | Nachricht | finanzen.net
![Sanofi-Aktie dennoch tiefer: EU-Ausschuss empfiehlt Dupixent bei Asthma für Kinder | 31.01.22 | finanzen.ch Sanofi-Aktie dennoch tiefer: EU-Ausschuss empfiehlt Dupixent bei Asthma für Kinder | 31.01.22 | finanzen.ch](https://images.finanzen.ch/images/unsortiert/sanofi_360b_660_83_w1320.jpg)